Wael El-Rifai
Overview
Explore the profile of Wael El-Rifai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
4375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim J, Jang G, Kang S, Lee G, Nga D, Phuong D, et al.
Cancer Res
. 2025 Mar;
85(6):1175.
PMID: 40083199
No abstract available.
2.
Chen L, Lu H, Ballout F, El-Rifai W, Chen Z, Gokulan R, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076620
Gastrointestinal (GI) cancers, which mainly include malignancies of the esophagus, stomach, intestine, pancreas, liver, gallbladder, and bile duct, pose a significant global health burden. Unfortunately, the prognosis for most GI...
3.
Paulrasu K, Gokulan R, El-Rifai W, Chen Z, Que J, Wang T, et al.
Cell Mol Gastroenterol Hepatol
. 2024 Dec;
19(3):101434.
PMID: 39637942
Background & Aims: Gastroesophageal reflux disease (GERD) is a common digestive disorder that is characterized by esophageal tissue damage produced by exposure of the esophageal lining to the gastric refluxate....
4.
Bhat N, Al-Mathkour M, Maacha S, Lu H, El-Rifai W, Ballout F
Front Mol Biosci
. 2024 Nov;
11:1440670.
PMID: 39600303
Esophageal adenocarcinoma (EAC) is a subtype of esophageal cancer with significant morbidity and mortality rates worldwide. Despite advancements in tumor models, the underlying cellular and molecular mechanisms driving EAC pathogenesis...
5.
Zhang Y, Karagiannis D, Liu H, Lin M, Fang Y, Jiang M, et al.
Sci Adv
. 2024 Oct;
10(41):eadq0479.
PMID: 39383220
While cell fate determination and maintenance are important in establishing and preserving tissue identity and function during development, aberrant cell fate transition leads to cancer cell heterogeneity and resistance to...
6.
Gomaa A, Maacha S, Peng D, Soutto M, Genoula M, Bhat N, et al.
Cancer Lett
. 2024 May;
593():216939.
PMID: 38729556
Helicobacter pylori (H. pylori) infection is the main risk factor for gastric cancer. The SRY-Box Transcription Factor 9 (SOX9) serves as a marker of stomach stem cells. We detected strong...
7.
Ballout F, Lu H, Bhat N, Chen L, Peng D, Chen Z, et al.
Clin Cancer Res
. 2024 Apr;
30(10):2193-2205.
PMID: 38592373
Purpose: TGFβ signaling is implicated in the progression of most cancers, including esophageal adenocarcinoma (EAC). Emerging evidence indicates that TGFβ signaling is a key factor in the development of resistance...
8.
Soutto M, Zhang X, Bhat N, Chen Z, Zhu S, Maacha S, et al.
Redox Biol
. 2023 Dec;
69:102998.
PMID: 38154380
Helicobacter pylori (H. pylori) is the leading risk factor for gastric carcinogenesis. Fibroblast growth factor receptor 4 (FGFR4) is a member of transmembrane tyrosine kinase receptors that are activated in...
9.
Zhu S, Soutto M, Chen Z, Piazuelo M, Washington M, Belkhiri A, et al.
Oncogene
. 2023 Dec;
43(3):224.
PMID: 38081964
No abstract available.
10.
Zhang Y, Karagiannis D, Liu H, Lin M, Fang Y, Jiang M, et al.
bioRxiv
. 2023 Sep;
PMID: 37745439
While cell fate determination and maintenance are important in establishing and preserving tissue identity and function during development, aberrant cell fate transition leads to cancer cell heterogeneity and resistance to...